What is the main business of Lipstore?

The main business activity of Lipstore focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 11, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Osikowa 5D, 26-026 Bilcza.

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $9,030,464, representing an increase of 19.8% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $784,028, meaning the company increased its profit by 246.8%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $340,473 in 2025, representing 4% of all operating expenses.

Lipstoresp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-10-11

Share capital

200,000.00 PLN

Registered address

ul. Osikowa 5D, 26-026 Bilcza, Poland

Website

lipstore.pl

Social media

Electronic delivery address

AE:PL-46800-92259-CHDRT-32

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 77 days early.

202509/04/2026
202423/05/2025
202324/04/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 9.03mMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 784.03kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 8.16mMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 1.80mMedianUSD 609.79kAverageUSD 11.85m

Industry

Offer

Lip fillers
Facial fillers
Body fillers
Volume enhancement products
Under-eye products
Wrinkle treatment products

Authorized Representatives

Michał Grochulski – Management Board Member

Przemysław Leszczyński – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Michał Grochulskiage 32	90	$48,622.37	90%
Przemysław Leszczyńskiage 31	10	$5,402.49	10%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-10-15.

ING Bank Śląski
15 1050 1416 1000 0090 8181 3686
ING Bank Śląski
27 1050 1416 1000 0090 8181 7059
ING Bank Śląski
53 1050 1416 1000 0090 8185 9465

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Eclipse Boluk-Sobolewskasp. k.	$10,235,697.61	eclipsemedical.pl
Citonet-Łódźsp. z o.o.	$9,932,231.75	citonet.pl
ODA Medicalsp. z o.o.	$9,414,794.43	odamedical.pl
Medicavera Dahlhausen Groupsp. z o.o.	$9,265,323.67	medicavera.pl
MedaseptS.A.	$8,612,031.18	medasept.pl
Novama CloudS.A.	$8,295,437.50	novama.cloud
MassmedicaS.A.	$8,216,274.00	massmedica.com
Diather Petrusewiczsp. k.	$7,399,375.09	diather.pl
Fortis Pharmaceuticalssp. z o.o.	$6,911,557.57	fortispharmaceuticals.pl
Euroleki Gksp. z o.o. + limited partnership	$6,866,421.91	euroleki.eu